These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23506242)

  • 1. Evaluation of a novel artificial pancreas: closed loop glycemic control system with continuous blood glucose monitoring.
    Tsukamoto Y; Kinoshita Y; Kitagawa H; Munekage M; Munekage E; Takezaki Y; Yatabe T; Yamashita K; Yamazaki R; Okabayashi T; Tarumi M; Kobayashi M; Mishina S; Hanazaki K
    Artif Organs; 2013 Apr; 37(4):E67-73. PubMed ID: 23506242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial.
    Okabayashi T; Nishimori I; Yamashita K; Sugimoto T; Maeda H; Yatabe T; Kohsaki T; Kobayashi M; Hanazaki K
    Arch Surg; 2009 Oct; 144(10):933-7. PubMed ID: 19841361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: the effects of no hypoglycemia.
    Hanazaki K; Kitagawa H; Yatabe T; Munekage M; Dabanaka K; Takezaki Y; Tsukamoto Y; Asano T; Kinoshita Y; Namikawa T
    Am J Surg; 2014 Jun; 207(6):935-41. PubMed ID: 24480234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients.
    Yatabe T; Yamazaki R; Kitagawa H; Okabayashi T; Yamashita K; Hanazaki K; Yokoyama M
    Crit Care Med; 2011 Mar; 39(3):575-8. PubMed ID: 21178768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between a novel and conventional artificial pancreas for perioperative glycemic control using a closed-loop system.
    Namikawa T; Munekage M; Kitagawa H; Yatabe T; Maeda H; Tsukamoto Y; Hirano K; Asano T; Kinoshita Y; Hanazaki K
    J Artif Organs; 2017 Mar; 20(1):84-90. PubMed ID: 27651347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of newly developed, next-generation artificial endocrine pancreas.
    Kambe N; Kawahito S; Mita N; Takaishi K; Katayama T; Sakai Y; Soga T; Kawano H; Matsuhisa M; Shimada M; Kitagawa T; Kitahata H
    J Med Invest; 2015; 62(1-2):41-4. PubMed ID: 25817282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closed-loop artificial endocrine pancreas from Japan.
    Hanazaki K; Tanioka N; Munekage M; Uemura S; Maeda H
    Artif Organs; 2021 Sep; 45(9):958-967. PubMed ID: 34105784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strict blood glucose control by an artificial endocrine pancreas during hepatectomy may prevent postoperative acute kidney injury.
    Mita N; Kawahito S; Soga T; Takaishi K; Kitahata H; Matsuhisa M; Shimada M; Kinoshita H; Tsutsumi YM; Tanaka K
    J Artif Organs; 2017 Mar; 20(1):76-83. PubMed ID: 27557726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot evaluation of continuous subcutaneous glucose monitoring in children with multiple organ dysfunction syndrome.
    Branco RG; Chavan A; Tasker RC
    Pediatr Crit Care Med; 2010 May; 11(3):415-9. PubMed ID: 19924024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative glycemic control using an artificial endocrine pancreas in patients undergoing total pancreatectomy: tight glycemic control may be justified in order to avoid brittle diabetes.
    Hanazaki K; Yatabe T; Kobayashi M; Tsukamoto Y; Kinoshita Y; Munekage M; Kitagawa H
    Biomed Mater Eng; 2013; 23(1-2):109-16. PubMed ID: 23442241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Questionnaire survey on the use of a novel artificial pancreas by intensive care unit nurses.
    Mibu K; Yatabe T; Yamasaki F; Kitagawa H; Munekage M; Namikawa T; Hanazaki K
    J Artif Organs; 2015 Jun; 18(2):162-5. PubMed ID: 25613744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdialysis based device for continuous extravascular monitoring of blood glucose.
    Feichtner F; Schaller R; Fercher A; Ratzer M; Ellmerer M; Plank J; Krause B; Pieber T; Schaupp L
    Biomed Microdevices; 2010 Jun; 12(3):399-407. PubMed ID: 20101469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an open access software for calculating glucose variability parameters of a continuous glucose monitoring system applied at pediatric intensive care unit.
    Marics G; Lendvai Z; Lódi C; Koncz L; Zakariás D; Schuster G; Mikos B; Hermann C; Szabó AJ; Tóth-Heyn P
    Biomed Eng Online; 2015 Apr; 14():37. PubMed ID: 25907677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of bedside artificial pancreas for postoperative glycemic control in cardiac surgery.
    Shin U; Naoko H; Michinori T; Yuya K; Yuka S; Yuki N; Motoharu K; Soichiro H; Mitsuo K; Yu Y; Tokito K; Satoru K; Kazuki D; Tetsuya O; Hirohisa M; Nobuhiko M; Takeshi O
    J Artif Organs; 2021 Jun; 24(2):225-233. PubMed ID: 33155103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas.
    Hirsch IB; Balo AK; Sayer K; Garcia A; Buckingham BA; Peyser TA
    Diabetes Technol Ther; 2017 Jun; 19(S3):S38-S48. PubMed ID: 28585873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automatic learning algorithm for the MD-logic artificial pancreas system.
    Miller S; Nimri R; Atlas E; Grunberg EA; Phillip M
    Diabetes Technol Ther; 2011 Oct; 13(10):983-90. PubMed ID: 21774690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status and issues of the artificial pancreas: abridged English translation of a special issue in Japanese.
    Namikawa T; Munekage M; Yatabe T; Kitagawa H; Hanazaki K
    J Artif Organs; 2018 Jun; 21(2):132-137. PubMed ID: 29356912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.